BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8552984)

  • 1. Engraftment and humoral immunity in SCID and RAG-2-deficient mice transplanted with human peripheral blood lymphocytes.
    Steinsvik TE; Gaarder PI; Aaberge IS; Løvik
    Scand J Immunol; 1995 Dec; 42(6):607-16. PubMed ID: 8552984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human antibody response to a pneumococcal vaccine in SCID-PBL-hu mice and simultaneously vaccinated human cell donors.
    Aaberge IS; Steinsvik TE; Groeng EC; Leikvold RB; Løvik M
    Clin Exp Immunol; 1996 Jul; 105(1):12-7. PubMed ID: 8697618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCID-Hu mice immunized with a pneumococcal vaccine produce specific human antibodies and show increased resistance to infection.
    Aaberge IS; Michaelsen TE; Rolstad AK; Groeng EC; Solberg P; Løvik M
    Infect Immun; 1992 Oct; 60(10):4146-53. PubMed ID: 1398925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human peripheral blood lymphocyte severe combined immunodeficiency (hu-PBL SCID) models of toxoplasmosis.
    Beaman MH; Remington JS; Meyer DJ
    Immunol Cell Biol; 2000 Dec; 78(6):608-15. PubMed ID: 11114971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific antibody production to a recall or a neoantigen by SCID mice reconstituted with human peripheral blood lymphocytes.
    Nonoyama S; Smith FO; Ochs HD
    J Immunol; 1993 Oct; 151(7):3894-901. PubMed ID: 8376809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total and birch pollen-specific human IgE in mice with severe combined immunodeficiency transplanted with human peripheral blood lymphocytes: donor dependence, seasonal variation and in vivo half-life.
    Steinsvik TE; Aaberge IS; Gaarder PI; Bjønness U; Løvik M
    Int Arch Allergy Immunol; 1997 Feb; 112(2):175-83. PubMed ID: 9030099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fate of human peripheral blood lymphocytes after transplantation into SCID mice.
    Martino G; Anastasi J; Feng J; Mc Shan C; DeGroot L; Quintans J; Grimaldi LM
    Eur J Immunol; 1993 May; 23(5):1023-8. PubMed ID: 8477797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of interleukin-4 in human immunoglobulin E formation in hu-PBL-SCID mice.
    Spiegelberg HL; Beck L; Kocher HP; Fanslow WC; Lucas AH
    J Clin Invest; 1994 Feb; 93(2):711-7. PubMed ID: 8113405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies.
    Williams SS; Umemoto T; Kida H; Repasky EA; Bankert RB
    J Immunol; 1992 Oct; 149(8):2830-6. PubMed ID: 1401915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of the hu-PBL-SCID mouse model to study lymphocyte homing and responsiveness to recall antigens.
    Lue C; Kiyono H; Fujihashi K; McGhee JR; Mestecky J
    Reg Immunol; 1992; 4(2):86-90. PubMed ID: 1503891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
    Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
    J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human primary immune response in SCID mice engrafted with human peripheral blood lymphocytes.
    Sandhu J; Shpitz B; Gallinger S; Hozumi N
    J Immunol; 1994 Apr; 152(8):3806-13. PubMed ID: 8144950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human peripheral blood leukocyte-reconstituted severe combined immunodeficient mouse: analysis of the human immune response against porcine islet transplantation.
    Shiroki R; Naziruddin B; Shishido S; Duffy BF; Howard T; Mohanakumar T
    Transplantation; 1997 Mar; 63(6):818-23. PubMed ID: 9089220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal macrophages play an important role in eliminating human cells from severe combined immunodeficient mice transplanted with human peripheral blood lymphocytes.
    Shibata S; Asano T; Noguchi A; Naito M; Ogura A; Doi K
    Immunology; 1998 Apr; 93(4):524-32. PubMed ID: 9659225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of human lymphocyte-engrafted SCID mice as a model for immunotoxicity assessment.
    Pollock PL; Germolec DR; Comment CE; Rosenthal GJ; Luster MI
    Fundam Appl Toxicol; 1994 Jan; 22(1):130-8. PubMed ID: 8125206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of human IgE response in hu-PBL-SCID mice.
    Kilchherr E; Mandak V; Wagner K; Heusser CH
    Cell Immunol; 1993 Oct; 151(2):241-56. PubMed ID: 8402934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term substitution and specific immune responses after transfer of bovine peripheral blood lymphocytes into severe combined immunodeficient mice.
    Hölscher C; Hasch G; Joswig N; Stauffer U; Müller U; Mossmann H
    Vet Immunol Immunopathol; 1999 Sep; 70(1-2):67-83. PubMed ID: 10507288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a cervical cancer model via inoculating SiHa Cells into humanized severe combined immunodeficient mice.
    Ye F; Chen H; Liang Z; Lu W; Cheng Q; Xie X
    Eur J Gynaecol Oncol; 2006; 27(6):566-72. PubMed ID: 17290584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for restricted diversity of antigen-specific human antibodies in immunized hu-PBL-SCID mice.
    Bazin R; Chevrier MC; Delage R; Lemieux R
    Hum Antibodies Hybridomas; 1996; 7(3):129-34. PubMed ID: 9057061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitation of Hu-PBL-scid mouse model in direct application to immunotoxicity assessment.
    Kim HM; Han SB; Hong DH; Yoo BS; Oh GT
    J Pharmacol Toxicol Methods; 1997 Mar; 37(2):83-9. PubMed ID: 9174983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.